Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. [electronic resource]
Producer: 20050308Description: 90-100 p. digitalISSN:- 0929-1903
- Antineoplastic Agents -- pharmacology
- Apoptosis
- Cell Survival
- DNA Damage
- Down-Regulation
- Gene Silencing
- Genes, Tumor Suppressor
- Germ-Line Mutation
- Humans
- Male
- PTEN Phosphohydrolase
- Phosphoric Monoester Hydrolases
- Prostatic Neoplasms -- genetics
- RNA Interference
- Radiation, Ionizing
- Receptor, IGF Type 1 -- biosynthesis
- Signal Transduction
- Tumor Suppressor Proteins
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.